| Literature DB >> 28569171 |
Francesca Amadori1, Elena Bardellini2,3, Giulio Conti4, Alessandra Majorana1.
Abstract
BACKGROUND: Adolescence is a period of transition to adulthood. Little is known about oral mucosal lesions (OMLs) in teenagers, in which the emergence of new habits, unfamiliar to children, could affect the type of lesions. The aim of this study was to evaluate the distribution of oral mucosal lesions (OMLs) in a wide sample of adolescents.Entities:
Keywords: Adolescent; Epidemiology; Oral mucosal lesion
Mesh:
Year: 2017 PMID: 28569171 PMCID: PMC5452358 DOI: 10.1186/s13052-017-0367-7
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Demographic and behavioral features of the patients with OMLs (n = 1544)
| Number | Percent | |
|---|---|---|
| Gender | ||
| Male | 587 | 38.1 |
| Female | 957 | 61.9 |
| Smoking | ||
| Smoker | 332 | 21.5 |
| Non-smoker | 1212 | 78.5 |
| Alcohol (3 or more glasses/week) | ||
| Yes | 803 | 52 |
| No | 741 | 48 |
| Systemic diseases | ||
| No | 939 | 60.8 |
| Yes | 605 | 39.2 |
Mean age 14.7 ± 0.8 years
OMLs in healthy patients and in adolescents with systemic diseases
| Type of oral lesion | Tot (%) | Healthy | Systemic diseases | OR (95% CI) |
|
|---|---|---|---|---|---|
| Apthous ulcers | 278 (18%) | 122 | 156 | 2.33 (1.79–3.03) | <0.001* |
| Traumatic ulcers | 221 (14.3%) | 113 | 108 | 1.59 (1.19–2.11) | 0.0014* |
| Herpes Simplex Virus infection (HSV) | 170 (11%) | 93 | 77 | 1.33 (0.96–1.83) | 0.0836 |
| Geographic tongue | 148 (9.6%) | 98 | 50 | 0.01 (0.01–0.02) | <0.001* |
| Candidiasis | 85 (5.5%) | 31 | 54 | 2.87 (1.82–4.52) | <0.001* |
| Morsicatio buccarum | 73 (4.7%) | 71 | 2 | 0.04 (0.01–0.17) | <0.001* |
| Fordyce’s granules | 66 (4.3%) | 37 | 29 | 0.98 (0.6–1.61) | 0.9401 |
| Focal Hyperkeratosis | 65 (4.2%) | 49 | 16 | 0.49 (0.29–0.88) | 0.0140* |
| Piercing lesions | 62 (4%) | 62 | 0 | - | <0.001* |
| Mucocele | 51 (3.3%) | 48 | 3 | 0.09 (0.03–0.3) | <0.001* |
| Peripheral fibroma | 43 (2.8%) | 34 | 9 | 0.4 (0.19–0.84) | 0.0129* |
| Gingival hyperplasia | 36 (2.3%) | 0 | 36 | - | <0.001* |
| Physiologic pigmentation (ethnic) | 34 (2.2%) | 34 | 0 | - | <0.001* |
| Hairy tongue | 32 (2.1%) | 20 | 12 | 0.93 (0.45–1.92) | 0.8432 |
| Linea alba | 30 (1.9%) | 27 | 3 | 1.59 (1.19–2.11) | 0.0014* |
| Congenital hemangiomas | 27 (1.75%) | 22 | 5 | 0.35 (0.13–0.92) | 0.0265* |
| Oral wart | 26 (1.7%) | 8 | 18 | 3.57 (1.54–8.26) | 0.0015* |
| Actinic cheilitis | 23 (1.5%) | 8 | 15 | 2.96 (1.25–7.02) | 0.0100* |
| Pyogenic granuloma | 21 (1.4%) | 21 | 0 | - | <0.001* |
| Smoking-associated melanosis | 11 (0.7%) | 11 | 0 | - | 0.0075* |
| Drug reactions | 7 (0.45%) | 5 | 2 | 0.62 (0.12–3.29) | 0.5643 |
| Leukoedema | 6 (0.4%) | 6 | 0 | - | 0.0488* |
| Iron deficiency anemia | 5 (0.3%) | 0 | 5 | - | 0.0053* |
| Contact allergies | 4 (0.25%) | 4 | 0 | - | 0.018* |
| Petechiae and ecchymoses | 3 (0.2%) | 0 | 3 | - | 0.0308* |
| Heavy metal pigmentation | 3 (0.2%) | 3 | 0 | - | 0.164 |
| Amalgam tattoo | 2 (0.13%) | 2 | 0 | - | 0.256 |
| Erythema multiforme | 2 (0.13%) | 2 | 0 | - | 0.256 |
| Oral lichen planus | 2 (0.13%) | 2 | 0 | - | 0.256 |
| Pleomorphic adenoma | 2 (0.13%) | 2 | 0 | - | 0.256 |
| Neurofibroma | 1 (0.06%) | 0 | 1 | - | 0.212 |
| Necrotizing sialometaplasia | 1 (0.06%) | 1 | 0 | - | 0.422 |
| Herpes Zoster infection | 1 (0.06%) | 1 | 0 | - | 0.422 |
| Pemphigus vulgaris | 1 (0.06%) | 1 | 0 | - | 0.422 |
| Dermatitis herpetiforme | 1 (0.06%) | 0 | 1 | - | 0.212 |
| Granular cell tumour | 1 (0.06%) | 1 | 0 | - | 0.422 |
* = significant, p < 0.05
Fig. 1Association between OMLs and the main systemic diseases